{"database": "lobbying", "table": "lobbying_activities", "rows": [[2311365, "3dca7968-ca8c-4d61-a1fc-4850dfc406eb", "Q2", "BLUE CROSS BLUE SHIELD OF MICHIGAN", 46676, "BLUE CROSS BLUE SHIELD OF MICHIGAN", 2019, "second_quarter", "PHA", "Opioids (Epidemic, Deterrence, Economic Impact Zones); CREATES Act;Drug Pricing; PBM/Prescription Drug Costs Rx Rebates; Direct-to-Consumer Rx Advertising;Rx Rebates; Biosimilars; Drug approval; \n\nH.R.1520 - 116th Congress (2019-2020)\nPurple Book Continuity Act of 2019\nSponsor: Rep. Eshoo, Anna G. [D-CA-18]\n\nH.R.1503 - 116th Congress (2019-2020)\nOrange Book Transparency Act of 2019\nSponsor: Rep. Kelly, Robin L. [D-IL-2] \n\nH.R.1499 - 116th Congress (2019-2020)\nProtecting Consumer Access to Generic Drugs Act of 2019\nSponsor: Rep. Rush, Bobby L. [D-IL-1]\n\nH.R.965 - 116th Congress (2019-2020)\nCREATES Act of 2019\nSponsor: Rep. Cicilline, David N. [D-RI-1]", "HOUSE OF REPRESENTATIVES,SENATE", null, 92595, 0, 0, "2019-07-18T16:18:08.480000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2311365"], "units": {}, "query_ms": 0.34433999098837376, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}